PARAMETRIC PORTFOLIO ASSOCIATES LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 141 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$4,475,000
+31.1%
90,414
+34.9%
0.00%0.0%
Q4 2021$3,413,000
-8.3%
67,017
+0.5%
0.00%0.0%
Q3 2021$3,720,000
+76.9%
66,690
+35.7%
0.00%
+100.0%
Q2 2021$2,103,000
+26.6%
49,145
+23.5%
0.00%0.0%
Q1 2021$1,661,000
-4.6%
39,798
+6.4%
0.00%0.0%
Q4 2020$1,742,000
+63.3%
37,396
+48.9%
0.00%0.0%
Q3 2020$1,067,000
-10.9%
25,107
+0.7%
0.00%0.0%
Q2 2020$1,197,000
-0.7%
24,942
-4.8%
0.00%0.0%
Q1 2020$1,205,000
-36.6%
26,197
-17.2%
0.00%0.0%
Q4 2019$1,900,000
-7.0%
31,623
-12.4%
0.00%
-50.0%
Q3 2019$2,043,000
-10.7%
36,119
-12.1%
0.00%0.0%
Q2 2019$2,288,000
+33.2%
41,094
+20.8%
0.00%
+100.0%
Q1 2019$1,718,000
+123.1%
34,032
+78.1%
0.00%0.0%
Q4 2018$770,000
-21.8%
19,107
+34.5%
0.00%0.0%
Q3 2018$985,000
+6.3%
14,211
+16.0%
0.00%0.0%
Q2 2018$927,000
-6.1%
12,246
-34.6%
0.00%0.0%
Q1 2018$987,000
-6.4%
18,725
-5.2%
0.00%0.0%
Q4 2017$1,055,000
+7.0%
19,743
+19.4%
0.00%0.0%
Q3 2017$986,000
+66.3%
16,532
+120.0%
0.00%0.0%
Q2 2017$593,000
+86.5%
7,515
+95.9%
0.00%
Q1 2017$318,000
-75.9%
3,836
-76.9%
0.00%
-100.0%
Q4 2016$1,320,000
+366.4%
16,635
+311.5%
0.00%
Q3 2016$283,000
+36.7%
4,043
+73.0%
0.00%
Q4 2015$207,0002,3370.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
JW Asset Management, LLC 475,755$25,068,00024.71%
Hudson Executive Capital LP 971,000$51,162,00015.09%
Park West Asset Management LLC 1,051,274$55,392,0002.47%
U S GLOBAL INVESTORS INC 19,200$1,012,0000.62%
Capital Impact Advisors, LLC 26,317$1,387,0000.57%
CLARK ESTATES INC/NY 56,278$2,965,0000.47%
IRIDIAN ASSET MANAGEMENT LLC/CT 873,131$46,005,0000.41%
ProQuest Associates IV LLC 6,777$357,0000.41%
Granite Investment Partners, LLC 114,207$6,017,0000.40%
GLOBEFLEX CAPITAL L P 30,900$1,628,0000.34%
View complete list of EAGLE PHARMACEUTICALS INC shareholders